References
- Shader R. I., Greenblatt D. J. Belladonna alkaloids and synthetic anticholinergics; uses and toxicity. Psychiatric Complications of Medical Drugs, R. I. Shader. Raven, New York 1972; 102–147
- Kaplan M. M., et al. A nonfatal case of intentional scopolamine poisoning. Clin. Toxicol. 1974; 7: 509–512
- Duvoisin R. C., Katz R. Reversal of central anticholinergic syndrome in man by physostigmine. J. Am. Med. Assoc. 1968; 206: 1963–1965
- Rumack B. H. Anticholinergic poisoning: Treatment with physostigmine. Pediatrics 1973; 52: 449–451
- Rumack B. H. Physostigmine use in drug overdose questioned (1). JACEP 1975; 4: 555–556
- Nattel S., Bayne L., Ruedy J. Physostigmine in coma due to drug overdose. Clin. Pharmacol. Ther. 1979; 25: 96–102
- Bayne W. F., Tao F. T., Crisologo N. Submicrogram assay for scopolamine in plasma and urine. J. Pharm. Sci. 1975; 64: 288–291
- Weiner N. Atropine, scopolamine and related antimuscarinic drugs. The Pharmacologic Basis of Therapeutics, 6th ed, A. G. Gilman, L. S. Goodman, A. Gilman. Macmillan, New York 1980; 126–127
- Mundy L., Zeller W. Acute toxic psychosis due to scopolamine. Dis. Nerv. Syst. 1958; 19: 423
- Biggs J. T., et al. Tricyclic antidepressant overdose. J. Am. Med. Assoc. 1977; 238: 135–138